NS
ACAD icon

NBC Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

NBC Securities’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Hold
735
– – ﹤0.01% 1670
2026
Q1 		$16.4K Hold
735
– – ﹤0.01% 1778
2025
Q4 		$19.6K Sell
735
-50
-6% -$1.2K ﹤0.01% 1782
2025
Q3 		$16.8K Sell
785
-50
-6% -$1.18K ﹤0.01% 1835
2025
Q2 		$18K Hold
835
– – ﹤0.01% 1744
2025
Q1 		$13K Buy
+835
New +$15.2K ﹤0.01% 1632
2024
Q4 		– Sell
-685
Closed -$10K – 1247
2024
Q3 		$10K Hold
685
– – ﹤0.01% 1717
2024
Q2 		$11K Buy
685
+175
+34% +$2.82K ﹤0.01% 1635
2024
Q1 		$9K Buy
510
+35
+7% +$867 ﹤0.01% 1719
2023
Q4 		$14K Hold
475
– – ﹤0.01% 1589
2023
Q3 		$9K Buy
+475
New +$12.9K ﹤0.01% 1721

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NBC Securities's ACAD Position: Q2 2026 in Review

NBC Securities held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 735 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

NBC Securities first reported a position in ACAD in Q3 2023 and has held it in 11 quarters since. The position peaked at $19.6K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • NBC Securities held 735 shares of Acadia Pharmaceuticals worth $18.6K as of Q2 2026.
  • NBC Securities left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1670 holding.
  • NBC Securities first reported a position in Acadia Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Acadia Pharmaceuticals position peaked at $19.6K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.